Schmalreck AF - Search Results

1

Identification of dermatophytes by Fourier transform infrared spectroscopy (FT-IR).

Bastert J, Korting HC, Traenkle P, Schmalreck AF. Bastert J, et al. Among authors: schmalreck af. Mycoses. 1999;42(9-10):525-8. doi: 10.1046/j.1439-0507.1999.00513.x. Mycoses. 1999. PMID: 10592695

2

[Differentiation and characterization of yeasts pathogenic for humans (Candida albicans, Exophiala dermatitidis) and algae pathogenic for animals (Prototheca spp.) using Fourier transform infrared spectroscopy (FTIR) in comparison with conventional methods].

Schmalreck AF, Tränkle P, Vanca E, Blaschke-Hellmessen R. Schmalreck AF, et al. Mycoses. 1998;41 Suppl 1:71-7. doi: 10.1111/j.1439-0507.1998.tb00587.x. Mycoses. 1998. PMID: 9717390 German.

3

[Fourier transform infrared spectroscopy, molecular biologic methods and antimyocotic susceptibility patterns for identification and differentiation of cryptococcus species].

Schmalreck AF, Hotzel H. Schmalreck AF, et al. Mycoses. 2000;43 Suppl 1:61-8. Mycoses. 2000. PMID: 11098628 German.

4

Candida africana sp. nov., a new human pathogen or a variant of Candida albicans?

Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. Tietz HJ, et al. Mycoses. 2001 Dec;44(11-12):437-45. doi: 10.1046/j.1439-0507.2001.00707.x. Mycoses. 2001. PMID: 11820255

5

[Species differentiation of yeasts of the genus Malassezia with Fourier transform infrared spectroscopy].

Kalinowska-Pujdak A, Schmalreck A, Haustein UF, Nenoff P. Kalinowska-Pujdak A, et al. Hautarzt. 2006 Feb;57(2):127-36. doi: 10.1007/s00105-005-1018-2. Hautarzt. 2006. PMID: 16170542 Clinical Trial. German.

6

[Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].

Kunzelmann V, Tietz HJ, Rossner D, Czaika V, Hopp M, Schmalreck A, Sterry W. Kunzelmann V, et al. Mycoses. 1996;39 Suppl 1:65-72. doi: 10.1111/j.1439-0507.1996.tb00508.x. Mycoses. 1996. PMID: 8767274 Clinical Trial. German.

7

[IWhich are the conditions for Cryptococcus neoformans var. neoformans-strains from avian excrements as a cause for human infections?].

Kielstein P, Hotzel H, Schmalreck A. Kielstein P, et al. Mycoses. 2002;45 Suppl 3:61-4. doi: 10.1111/j.1439-0507.2002.tb04772.x. Mycoses. 2002. PMID: 12690974 German.

8

[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].

Czaika V, Tietz HJ, Schmalreck A, Sterry W, Schultze W. Czaika V, et al. Mycoses. 2000;43 Suppl 2:45-50. Mycoses. 2000. PMID: 11291577 German.

9

Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.

Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K; Antifungal Susceptibility Testing-AFST Study Group. Schmalreck AF, et al. Mycoses. 2012 May;55(3):e124-37. doi: 10.1111/j.1439-0507.2011.02165.x. Epub 2012 Jan 11. Mycoses. 2012. PMID: 22233267

10

An evaluation of seven methods of testing in vitro susceptibility of clinical yeast isolates to fluconazole.

Schmalreck AF, Kottmann I, Reiser A, Ruffer U, Scharr E, Vanca E. Schmalreck AF, et al. Mycoses. 1995 Sep-Oct;38(9-10):359-68. doi: 10.1111/j.1439-0507.1995.tb00065.x. Mycoses. 1995. PMID: 8569810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters